151 related articles for article (PubMed ID: 33228460)
1. Understanding binding between donepezil and human ferritin: molecular docking and molecular dynamics simulation approach.
Shahwan M; Khan MS; Husain FM; Shamsi A
J Biomol Struct Dyn; 2022 Jun; 40(9):3871-3879. PubMed ID: 33228460
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Interaction of Human Ferritin with Quercetin and Naringenin: Implication of Natural Products in Neurodegenerative Diseases: Molecular Docking and Dynamics Simulation Insight.
Shamsi A; Shahwan M; Khan MS; Husain FM; Alhumaydhi FA; Aljohani ASM; Rehman MT; Hassan MI; Islam A
ACS Omega; 2021 Mar; 6(11):7922-7930. PubMed ID: 33778303
[TBL] [Abstract][Full Text] [Related]
3. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
5. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
6. Computational insight into the binding of bryostatin 1 with ferritin: implication of natural compounds in Alzheimer's disease therapeutics.
Shahwan M; Alhumaydhi FA; Sharaf SE; Alghamdi BS; Baeesa S; Tayeb HO; Ashraf GM; Shamsi A
J Biomol Struct Dyn; 2023; 41(12):5635-5645. PubMed ID: 35787781
[TBL] [Abstract][Full Text] [Related]
7. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
Ghosh S; Jana K; Ganguly B
Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer's drug donepezil with human transferrin: implications of Alzheimer's drug.
Shamsi A; Al Shahwan M; Ahamad S; Hassan MI; Ahmad F; Islam A
J Biomol Struct Dyn; 2020 Mar; 38(4):1094-1102. PubMed ID: 30898045
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
Koly HK; Sutradhar K; Rahman MS
J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
[TBL] [Abstract][Full Text] [Related]
11. Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction.
Honorio P; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2022 Dec; 368():110227. PubMed ID: 36302488
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3-Hydroxypyridine-4-one Derivatives as Potential Acetylcholinesterase Inhibitors.
Asgarshamsi MH; Fassihi A; Dehkordi MM
Chem Biodivers; 2023 Jul; 20(7):e202300325. PubMed ID: 37347200
[TBL] [Abstract][Full Text] [Related]
13. The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression.
Li X; Li J; Huang Y; Gong Q; Fu Y; Xu Y; Huang J; You H; Zhang D; Zhang D; Mao F; Zhu J; Wang H; Zhang H; Li J
Eur J Med Chem; 2022 Feb; 229():114045. PubMed ID: 34922191
[TBL] [Abstract][Full Text] [Related]
14. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
15. Molecular evaluation of herbal compounds as potent inhibitors of acetylcholinesterase for the treatment of Alzheimer's disease.
Chen YX; Li GZ; Zhang B; Xia ZY; Zhang M
Mol Med Rep; 2016 Jul; 14(1):446-52. PubMed ID: 27176468
[TBL] [Abstract][Full Text] [Related]
16. MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.
Shamsi A; Anwar S; Mohammad T; Alajmi MF; Hussain A; Rehman MT; Hasan GM; Islam A; Hassan MI
Biomolecules; 2020 May; 10(5):. PubMed ID: 32443670
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
[TBL] [Abstract][Full Text] [Related]
18. Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study.
Rocha REO; Lima LHF
J Biomol Struct Dyn; 2019 Apr; 37(7):1843-1856. PubMed ID: 29697300
[TBL] [Abstract][Full Text] [Related]
19. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL
Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
